Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Allergy and Immunology
Trial Title   A randomized, double-blind, double-dummy, placebo-controlled, parallel-group study to assess & compare efficacy & safety of an 8-week treatment with Respimat® inhaler & fluticason propionate in patients with asthma inadequately controlled on SABA therapy
Description of Research   The aim of this clinical study is to compare the efficacy and safety of three different doses of BI 54903 with fluticasone and so-called placebo (a compound that is identical in appearance to the study medication but does not contain any active ingredient).
Study Number   HSR-11-1235
Inclusion/Notes   Patients with asthma may take part in this study if they are being treated with low to medium doses of an inhaled corticosteroid.
Principal Investigator   Jeffrey Leflein, MD
Contact Name   Patricia Lezak, CCRC
Phone   (734) 528-0477
A Member of Trinity Health
© 2015 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456